Draft for Comments || Submission of Position Paper/Comments on the Draft Administrative Order entitled “Implementing Guidelines on the Schedule of Fees and Charges of the Food and Drug Administration for Licensing, Registration and Other Authorizations and Regulatory Services Repealing Administrative Order No. 50s. 2001, “Revised 2001 Schedule of Fees and Charges for the Corresponding Services Rendered by the Bureau of Food and Drugs” and its Amendments

This refers to the public consultation on the FDA’s new schedule of Fees and Charges conducted virtually on 27 October 2023 and face-to-face on 29-30 November 2023. All concerned FDA Stakeholders are enjoined to submit their position paper/comments on or before 15 December 2023 to the FDA Policy and Planning Service thru email at [email protected].

Here with are the following documents for your reference:

1) Latest version of the Draft Administrative Order

2) Annexes for the new Schedules of Fees and Charges

3) Breakdown of Cost as per DOF-DBM-NEDA Joint Circular No. 1-2013

For queries and further clarifications, please get in touch directly with Mr. Philip Charles T. Calaor, Food-Drug Regulation Officer II via [email protected].

Thank you very much.